Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma(397 views) De Luca S, Fonti R, Camera L, Salvatore B, Faggiano A, Ciarmiello A, Segreto S, Colao A, Salvatore M, Del Vecchio S
Ann Nucl Med (ISSN: 0914-7187, 1864-6433, 0914-7187linking), 2016 Jan 11; 30(3): 1-8.
Department of Advanced Biomedical Sciences, University of Naples Federico II, Via Pansini 5, Edificio 10, 80131, Naples, Italy., Institute of Biostructures and Bioimages, National Research Council, Naples, Italy., Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Nuclear Medicine Department, Hospital S. Andrea, La Spezia, Italy., IRCCS-SDN, Naples, Italy., Department of Advanced Biomedical Sciences, University of Naples Federico II, Via Pansini 5, Edificio 10, 80131, Naples, Italy. delvecc@unina.it., Institute of Biostructures and Bioimages, National Research Council, Naples, Italy. delvecc@unina.it.,
References: Not available.
Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma